Eli Lilly to buy Centessa Pharma in $6.3 billion deal
March 31 (Reuters) - Eli Lilly LLY.N said on Tuesday it would buy Centessa Pharmaceuticals 260y.F in a deal worth about $6.3 billion to advance treatments for sleep-wake disorders. (Reporting by Sneha S K) ((Sneha.SK@thomsonreuters.com;))
Recent news on Centessa Pharmaceuticals
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Acquisition Of Centessa By Lilly Approved By The High Court Of Justice Of England And Wales
Street View: Lilly's $7.8 billion Centessa buyout validates sleep‑drug market
Press Digest: New York Times business news - April 1